Apr 26, 2024
- Corporate
Notice of Completion of Disposal of Treasury Shares as Restricted Stock Compensation Plan
| Name of listed company: | Chugai Pharmaceutical Co., Ltd. |
| Code number: | 4519 (Prime Market of Tokyo Stock Exchange) |
| Head office: | 1-1, Nihonbashi-Muromachi 2-Chome, Chuo-ku, Tokyo |
| President & CEO: | Osamu Okuda |
| Inquiries to: | Kae Miyata |
| Head of Corporate Communications Dept. | |
| Tel:+81-(0)3-3273-0554 |
TOKYO, April 26, 2024-- Chugai Pharmaceutical Co., Ltd. announced that disposal of treasury shares was completed today, as we announced in the press release “Notice of Disposal of Treasury Shares as Restricted Stock Compensation Plan” on March 28, 2024. The result of treasury shares is as follows.
- Overview of Disposal
- Disposal date: April 26, 2024
- Class and number of disposed shares: 100,200 shares of Common stock of the Company
- Disposal price: ¥5,927 per share
- Total value of disposed shares: ¥593,885,400
- Allottees and number thereof; number of disposed shares:
Directors 3 38,800 shares Vice presidents 11 22,000 shares Employees 105 35,500 shares Director of subsidiaries 4 1,200 shares Employees of subsidiaries 9 2,700 shares
Contact:
- For Media
- Chugai Pharmaceutical Co., Ltd.
- Media Relations Group, Corporate Communications Dept.,
- Hideki Sato
- Tel: +81-3-3273-0881
- E-mail: pr@chugai-pharm.co.jp
- For Investors
- Chugai Pharmaceutical Co., Ltd.
- Investor Relations Group, Corporate Communications Dept.,
- Takayuki Sakurai
- Tel: +81-3-3273-0554
- E-mail: ir@chugai-pharm.co.jp
